Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 26

Related Articles by Review for PubMed (Select 23100302)

1.

HCT survival in ADA-SCID: what's the buzz?

Chan SK, Shearer WT.

Blood. 2012 Oct 25;120(17):3392-3. doi: 10.1182/blood-2012-07-443960.

2.

Update on gene therapy for adenosine deaminase-deficient severe combined immunodeficiency.

Ferrua F, Brigida I, Aiuti A.

Curr Opin Allergy Clin Immunol. 2010 Dec;10(6):551-6. doi: 10.1097/ACI.0b013e32833fea85. Review.

PMID:
20966749
3.

Management options for adenosine deaminase deficiency; proceedings of the EBMT satellite workshop (Hamburg, March 2006).

Booth C, Hershfield M, Notarangelo L, Buckley R, Hoenig M, Mahlaoui N, Cavazzana-Calvo M, Aiuti A, Gaspar HB.

Clin Immunol. 2007 May;123(2):139-47. Epub 2007 Feb 14. Review.

PMID:
17300989
4.

Bone marrow transplantation and alternatives for adenosine deaminase deficiency.

Gaspar HB.

Immunol Allergy Clin North Am. 2010 May;30(2):221-36. doi: 10.1016/j.iac.2010.01.002. Review.

PMID:
20493398
5.

Enzyme replacement therapy of adenosine deaminase deficiency with polyethylene glycol-modified adenosine deaminase (PEG-ADA).

Hershfield MS.

Immunodeficiency. 1993;4(1-4):93-7. Review. No abstract available.

PMID:
8167743
6.

Bone marrow gene therapy for adenosine deaminase deficiency.

Kaptein LC, Einerhand MP, Braakman E, Valerio D, van Beusechem VW.

Immunodeficiency. 1993;4(1-4):335-45. Review.

PMID:
7909479
7.

Adenosine deaminase deficiency as the first target disorder in gene therapy.

Onodera M, Sakiyama Y.

Expert Opin Investig Drugs. 2000 Mar;9(3):543-9. Review.

PMID:
11060694
8.

Gene therapy for adenosine deaminase deficiency.

Cappelli B, Aiuti A.

Immunol Allergy Clin North Am. 2010 May;30(2):249-60. doi: 10.1016/j.iac.2010.02.003. Review.

PMID:
20493400
9.

How I treat ADA deficiency.

Gaspar HB, Aiuti A, Porta F, Candotti F, Hershfield MS, Notarangelo LD.

Blood. 2009 Oct 22;114(17):3524-32. doi: 10.1182/blood-2009-06-189209. Epub 2009 Jul 28. Review.

10.
11.

Gene therapy for severe combined immunodeficiency caused by adenosine deaminase deficiency: improved retroviral vectors for clinical trials.

Onodera M, Nelson DM, Sakiyama Y, Candotti F, Blaese RM.

Acta Haematol. 1999;101(2):89-96. Review.

PMID:
10202239
12.

Gene therapy for adenosine deaminase deficiency.

Aiuti A, Ficara F, Cattaneo F, Bordignon C, Roncarolo MG.

Curr Opin Allergy Clin Immunol. 2003 Dec;3(6):461-6. Review.

PMID:
14612670
14.

Gene therapy for hematopoietic and immune disorders.

Kohn DB.

Bone Marrow Transplant. 1996 Dec;18 Suppl 3:S55-8. Review.

PMID:
8971410
15.

HLA-haploidentical donor transplantation in severe combined immunodeficiency.

Friedrich W, Hönig M.

Immunol Allergy Clin North Am. 2010 Feb;30(1):31-44. doi: 10.1016/j.iac.2009.11.004. Review.

PMID:
20113885
16.

[Gene therapy for adenosine deaminase deficiency].

Sakiyama Y.

Hokkaido Igaku Zasshi. 1996 Jan;71(1):27-32. Review. Japanese.

PMID:
8727372
17.

Gene therapy for severe combined immunodeficiencies.

Gaspar HB, Thrasher AJ.

Expert Opin Biol Ther. 2005 Sep;5(9):1175-82. Review.

PMID:
16120048
18.

[Adenosine deaminase deficiency].

Okawa H.

Ryoikibetsu Shokogun Shirizu. 1998;(21 Pt 2):240-2. Review. Japanese. No abstract available.

PMID:
9833480
19.

New insights into the pathogenesis of adenosine deaminase-severe combined immunodeficiency and progress in gene therapy.

Sauer AV, Aiuti A.

Curr Opin Allergy Clin Immunol. 2009 Dec;9(6):496-502. doi: 10.1097/ACI.0b013e3283327da5. Review.

PMID:
19779332
20.

Ten years of gene therapy for primary immune deficiencies.

Aiuti A, Roncarolo MG.

Hematology Am Soc Hematol Educ Program. 2009:682-9. doi: 10.1182/asheducation-2009.1.682. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk